The synovial secretome contributes to cartilage pathology in osteoarthritis (OA): an Exosome Study

Sabha Asghar, Gary Litherland, Dominic Meek, Carl Goodyear, John Lockhart, Anne Crilly

Research output: Contribution to conferencePoster

Abstract

Background. Osteoarthritis (OA) is no longer considered only a disease of the cartilage, with disruption of synovial tissue homeostasis a recognised feature. The aim of this study was to characterise the OA synovial secretome (including soluble inflammatory mediators and exosome content) and uptake of isolated exosomes by primary OA chondrocytes, thereby interrogating potential tissue communication pathways in OA.
Methodology. Human OA synovial explants were cultured in the presence/absence of IL-1β or protease activated receptor (PAR)2 agonist peptide (SLIGKV-NH2) or reverse peptide (RP). Conditioned medium (CM) was harvested after 48h (n=13). Dead cells and debris were eliminated by successive centrifugations at increasing speeds, with exosomes isolated by ultracentrifuge. Western blot analysis was used to confirm the presence of exosome markers (CD9, CD81, HSP70 and CD63), with scanning electron microscopy (SEM) used to verify exosome size. Isolated exosomes were labelled with Exo-Red (stains RNA) or Exo-Green (stains protein) and uptake by primary human OA chondrocytes evaluated using immunofluorescence imaging. Cytokine levels in CM were evaluated using ELISA.
Results. Exosome isolation success was determined by the presence of associated markers, with a size range of 30-150 nm. Stimulation with IL-1β or SLIGKV-NH2 did not significantly alter the protein concentration of the preparations. Exosomes carried protein and RNA cargo (as evidenced by specific staining) and were taken up by primary chondrocytes after 4h exposure. Levels of IL-6, TNFα and MMP-3 in CM were significantly increased by both IL-1β (p<0.001). Interestingly, only SLIGKV-NH2 significantly increased IL-8 (p<0.001), demonstrating differential regulation by PAR2.
Conclusion. OA synovial tissue has the potential to impact chondrocyte behaviour through the release of soluble mediators and exosomes. Future studies exploring both chondrocyte gene expression post exosome uptake, and characterisation of cargo, will provide insight into the role of the synovium in OA cartilage pathology.Sponsored by: University of the West of Scotland PhD Studentship, Arthritis Research UK (reference no. 4988) & Tenovus Scotland (reference no. S16/16)
Original languageEnglish
Publication statusAccepted/In press - 5 Dec 2017
Event2017 British Society for Immunology Congress - Brighton, United Kingdom
Duration: 4 Dec 20177 Dec 2017
http://www.bsicongress.com/full-programme/

Conference

Conference2017 British Society for Immunology Congress
Abbreviated titleBSI
CountryUnited Kingdom
CityBrighton
Period4/12/177/12/17
Internet address

Keywords

  • Exosomes
  • Extracellular vesicles
  • Inflammation
  • Osteoarthritis
  • Cartilage, Articular
  • Synovial Membrane
  • Synovitis

Fingerprint Dive into the research topics of 'The synovial secretome contributes to cartilage pathology in osteoarthritis (OA): an Exosome Study'. Together they form a unique fingerprint.

  • Cite this

    Asghar, S., Litherland, G., Meek, D., Goodyear, C., Lockhart, J., & Crilly, A. (Accepted/In press). The synovial secretome contributes to cartilage pathology in osteoarthritis (OA): an Exosome Study. Poster session presented at 2017 British Society for Immunology Congress, Brighton, United Kingdom.